Skip to content
healthcare.dev

AVLAYAH

NDC 84976-001, tividenofusp alfa-eknm, injection, powder, lyophilized, for solution, from Denali Therapeutics Inc..

Product NDC
84976-001
Status
Listed
Labeler
Denali Therapeutics Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761485
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84976-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIVIDENOFUSP ALFA150 mg/5mL
Package NDCNDC-11Package
84976-001-01849760001011 VIAL in 1 CARTON (84976-001-01) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/014d92c1-b643-4680-8ca6-f0b3307da915

Use it

Look up 84976-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84976-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84976-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.